参考文献/References:
[1]Galluzzi L,Vitale I,Aaronson SA,et al.Molecular mechanisms of cell death:recommendations of the nomenclature committee on cell death 2018[J].Cell Death Differ,2018,25(3):486-541.
[2]Zhu H,SunA.Programmed necrosis in heart disease:molecular mechanisms and clinical implications[J].J Mol Cell Cardiol,2018,116:125-134.
[3]Chen Y,Smith MR,Thirumalai K,et al.A bacterial invasin induces macrophage apoptosis by binding directly to ICE[J].EMBO J,1996,15(15):3853-3860.
[4]Xu YJ,Zheng L,Hu YW,et al.Pyroptosis and its relationship to atherosclerosis[J].Clin Chim Acta,2018,476:28-37.
[5]Kawaguchi M,Takahashi M,Hata T,et al.Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury[J].Circulation,2011,123(6):594-604.
[6]Luo B,Huang F,Liu Y,et al.NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy[J].Front Physiol,2017,8:519.
[7]Mulvihill E,Sborgi L,Mari SA,et al.Mechanism of membrane pore formation by human gasdermin-D[J].EMBO J,2018,37(14):e98321.
[8]Ryu JC,Kim MJ,Kwon Y,et al.Neutrophil pyroptosis mediates pathology of P.aeruginosa lung infection in the absence of the NADPH oxidase NOX2[J].Mucosal Immunol,2017,10(3):757-774.
[9]Yang X,Lin G,Han Z,et al.Structural biology of NOD-like receptors[J].Adv Exp Med Biol,2019,1172:119-141.
[10]Nambayan RJT,Sandin SI,Quint DA,et al.The inflammasome adapter ASC assembles into filaments with integral participation of its two Death Domains,PYD and CARD[J].J Biol Chem,2019,294(2):439-452.
[11]deTorre-Minguela C,Mesa Del Castillo P,Pelegrín P.The NLRP3 and pyrin inflammasomes:implications in the pathophysiology of autoinflammatory diseases[J].Front Immunol,2017,8:43.
[12]He WT,Wan H,Hu L,et al.Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion[J].Cell Res,2015,25(12):1285-1298.
[13]Shi J,Zhao Y,Wang K,et al.Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J].Nature,2015,526(7575):660-665.
[14]Lagrange B,Benaoudia S,Wallet P,et al.Human caspase-4 detects tetra-acylated LPS and cytosolic francisella and functions differently from murine caspase-11[J].Nat Commun,2018,9(1):242.
[15]Shi J,Gao W,Shao F.Pyroptosis:gasdermin-mediated programmed necrotic cell death[J].Trends Biochem Sci,2017,42(4):245-254.
[16]Sborgi L,Ruhl S,Mulvihill E,et al.GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death[J].EMBO J,2016,35(16):1766-1778.
[17]Agliettia RA,Estevez A,Gupta A,et al.GSDMD p30 elicited by caspase-11 during pyroptosis forms pores in membranes[J].Proc Natl Acad Sci USA,2016,113(28):7858-7863.
[18]Ding J,Wang K,Liu W,et al.Pore-forming activity and structural autoinhibition of the gasdermin family[J].Nature,2016,535(7610):111-116.
[19]Kayagaki N,Stowe IB,Lee BL,et al.Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling[J].Nature,2015,526(7575):666-671.
[20]Zhou W,Chen C,Chen Z,et al.NLRP3:a novel mediator in cardiovascular disease[J].J Immunol Res,2018,2018:5702103.
[21]Zhu Y,Xian X,Wang Z,et al.Research progresson on the relationship between atherosclerosis and inflammation[J].Biomolecules,2018,8(3):80.
[22]Duewell P,Kono H,Rayner KJ,et al.NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals[J].Nature,2010,464(7293):1357-1361.
[23]Wu X,Zhang H,Qi W,et al.Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis[J].Cell Death Dis,2018,9(2):171.
[24]Shi X,Xie WL,Kong WW,et al.Expression of the NLRP3 inflammasome in carotid atherosclerosis[J].J Stroke Cerebrovasc Dis,2015,24(11):2455-2466.
[25]Zheng F,Gong Z,Xing S,et al.Overexpression of caspase-1 in aorta of patients with coronary atherosclerosis[J].Heart Lung Circ,2014,23(11):1070-1074.
[26]Gage J,Hasu M,Thabet M,et al.Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice[J].Can J Cardiol,2012,28(2):222-229.
[27]林莉,韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,40(7):1039-1042.
[28]Afrasyab A,Qu P,Zhao Y,et al.Correlation of NLRP3with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients[J].Heart Vessels,2016,31(8):1218-1229.
[29]Mezzaroma E,Toldo S,Farkas D,et al.The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse[J].Proc Natl Acad Sci USA,2011,108(49):19725-19730.
[30]Takahashi M.NLRP3 inflammasome as a novel player in myocardial infarction[J].Int Heart J,2014,55(2):101-105.
[31]Marchetti C,Chojnacki J,Toldo S,et al.A novel pharmacologic inhibitor of the NLPP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse[J].J Cardiovasc Pharmacol,2014,63(4):316-322.
[32]Jia G,Whaley-Connell A,Sowers JR.Diabetic cardiomyopathy:a hyperglycaemia and insulin resistance induced heart disease[J].Diabetologia,2018,61(1):21-28.
[33]Li X,Du N,Zhang Q,et al.MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy[J].Cell Death Dis,2014,5(10):e1479.
[34]Giordano A,Murano I,Mondini E,et al.Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis[J].J Lipid Res,2013,54(9):2423-2436.
[35]Stienstra R,van Diepen JA,Tack CJ,et al.Inflammasome is a central player in the induction of obesity and insulin resistance[J].Proc Natl Acad Sci U S A,2011,108(37):15324-15329.
[36]Kim Y,Wang W,Okla M,et al.Suppression of NLRP3 inflammasome by gamma-tocotrienol ameliorates type 2 diabetes[J].J Lipid Res,2016,57(1):66-76.
[37]Toldo S,Abbate A.The NLRP3 inflammasome in acute myocardial infarction[J].Nat Rev Cardiol,2018,15(4):203-214.
[38]Krishnan SM,Dowling JK,Ling YH,et al.Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice[J].Br J Pharmacol,2016,173(4):752-765.
相似文献/References:
[1]王盛姣 关秀茹.MicroRNA与细胞焦亡在动脉粥样硬化中的作用研究[J].心血管病学进展,2020,(5):521.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.019]
WANG Shengjiao,GUAN Xiuru.MicroRNA and Pyroptosis in Atherosclerosis[J].Advances in Cardiovascular Diseases,2020,(7):521.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.019]
[2]朱晓龙侯阳.细胞焦亡的分子机制其在心血管病变中的研究进展[J].心血管病学进展,2020,(8):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
ZHU Xiaolong,HOU Yang.Molecular Mechanism of yroptosis and Its Research Progress in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(7):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
[3]韩敏 朱兵 余嘉清 马依彤.程序性细胞死亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(10):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
HAN MinZHU BingYU JiaqingMA Yitong. Programmed Cell Death and Myocardial Ischemic Reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(7):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
[4]郭双 邢栋 吕勃.程序性坏死、细胞焦亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(12):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
GUO Shuang,XING Dong,LYU Bo.NecroptosisPyroptosis and Myocardial Ischemia-reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(7):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
[5]吴浩亮,周文杰,崔胜宇,等.NLRP3炎症小体在病理性心肌肥厚中的研究进展[J].心血管病学进展,2022,(10):923.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.014]
WU Haoliang,ZHOU Wenjie,CUI Shengyu,et al.NLRP3 Inflammasome in Pathological Cardiac Hypertrophy[J].Advances in Cardiovascular Diseases,2022,(7):923.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.014]
[6]李心瑶 陈俊 李灼.脓毒症心肌病的发病机制研究进展[J].心血管病学进展,2024,(1):44.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.012]
LI Xinyao,CHEN Jun,LI Zhuo.Pathogenesis of Septic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2024,(7):44.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.012]